La  hiperostosis esquelética idiopática difusa como expresión de un proceso sistémico

Alberto Omar Orden; Alberto Omar Orden

doi:10.47196/rar.v28i2.562

Alberto Omar Orden Hospital Aeronáutico Central, Buenos Aires, Argentina
Alberto Omar Orden Hospital Aeronáutico Central, Buenos Aires, Argentina

DOI: https://doi.org/10.47196/rar.v28i2.562

Palabras clave: actualización

Resumen

La Hiperostosis Esquelética Idiopática Difusa es una condición caracterizada por la calcificación y/u osificación de los tejidos blandos, principalmente entesis, ligamentos y cápsulas articulares. En 1950, Forestier y Rotés-Querol publicaron una serie denominándola “hiperostosis anquilosante vertebral senil” y la distinguieron como entidad nosológica separada de la espondiloartrosis y la espondilitis anquilosante.

Biografía del autor/a

Alberto Omar Orden, Hospital Aeronáutico Central, Buenos Aires, Argentina

Servicio de Reumatología

Alberto Omar Orden, Hospital Aeronáutico Central, Buenos Aires, Argentina

Servicio de Reumatología

Citas

I. Forestier J, Rotés-Querol J. Senile ankylosing hyperostosis of the spine. Ann Rheum Dis 1950; 9:321-30.

II. Resnick D, Shaul SR, Robins JM. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology 1975; 115:513-24.

III. Epstein N. Ossification of the cervical posterior longitudinal ligament: a review. Neurosurg Focus 2002; 13:ECP1.

IV. El Miedany YM, Wassif G, El Baddini M. Diffuse idiopathic skeletal hyperostosis (DISH): is it of vascular aetiology? Clin Exp Rheumatol 2000;18:193-200.

V. Mader R, Sarzi-Puttini P, Atzeni F, et al. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) 2009; 48:1478-81.

VI. Rillo OL, Scheines EJ, Moreno C, Barreira JC, Porrini AA, Maldonado Cocco JA. Coexistence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis. Clin Rheumatol. 1989 Dec; 8(4):499-503.

VII. Rotés-Querol J. Clinical manifestations of diffuse idiopathic skeletal hyperostosis (DISH). Br J Rheumatol 1996; 35:1193-4.

VIII. Castellano DM, Sinacori JT, Karakla DW. Stridor and dysphagia in diffuse idiopathic skeletal hyperostosis (DISH). Laryngoscope 2006; 116:341-4.

IX. Ebo DG, Uytterhaegen PJ, Lagae PL, et al. Choking, sore throat with referred otalgia and dysphagia in a patient with diffuse idiopathic skeletal hyperostosis (DISH). Acta Clin Belg 2005; 60:98-101.

X. Sreedharan S, Li YH. Diffuse idiopathic skeletal hyperostosis with cervical spinal cord injury -a report of 3 cases and a literature review. Ann Acad Med Singapore 2005; 34:257-61.

XI. Lee SH. Spinal subarachnoid hematoma with hyperextension lumbar fracture in diffuse skeletal hyperostosis: a case report. Spine (Phila Pa 1976) 2009; 34:E673-6.

XII. Kim SK, Choi BR, Kim CG, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in Korea. J Rheumatol 2004; 31:2032-5.

XIII. Julkunen H, Heinonen OP, Knekt P, Maatela J. The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 1975; 4:23-7.

XIV. Westerveld LA, van Ufford HM, Verlaan JJ, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in The Netherlands. J Rheumatol 2008; 35:1635-8.

XV. Pappone N, Lubrano E, Esposito-del Puente A, et al. Prevalence of diffuse idiopathic skeletal hyperostosis in a female Italian population. Clin Exp Rheumatol 2005; 23:123-4.

XVI. Kiss C, O’Neill TW, Mituszova M, et al. Prevalence of diffuse idiopathic skeletal hyperostosis in Budapest, Hungary. Rheumatology (Oxford) 2002; 41:1335-6.

XVII. Weinfeld RM, Olson PN, Maki DD, et al. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 1997; 26:222-5.

XVIII. Boachie-Adjei O, Bullough PG. Incidence of ankylosing hyperostosis of the spine (Forestier’s disease) at autopsy. Spine 1987; 12:739-43.

XIX. Cassim B, Mody G, Rubin D. The prevalence of diffuse idiopathic skeletal hyperostosis in African blacks. Br J Rheumatol 1990; 29:131-2.

XX. Bloom RA. The prevalence of ankylosing hyperostosis in a Jerusalem population--with description of a method of grading the extent of the disease. Scand J Rheumatol 1984; 13:181-9.

XXI. Julkunen H, Knekt P, Aromaa A. Spondylosis deformans and diffuse idiopathic skeletal hyperostosis (DISH) in Finland. Scand J Rheumatol 1981; 10:193-203.

XXII. Mazières B. Diffuse idiopathic skeletal hyperostosis (Forestier-Rotés-Querol disease): What’s new? Joint Bone Spine 2013 Apr 5. doi: 10.1016/j.jbspin.2013 .02.011.

XXIII. Utsinger PD. Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis 1985;11:325-51.

XXIV. Mader R, Buskila D, Verlaan JJ, et al. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. Rheumatology (Oxford) 2013; 52:326-30.

XXV. Resnick D, Niwayama G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 1976; 119:559-68.

XXVI. Arlet J, Mazieres B. La maladie hyperostosique. Rev Med Interne 1985; 6:553-64.

XXVII. Karasik D, Kiel DP, Kiely DK, et al. Abdominal aortic calcification and exostoses at the hand and lumbar spine: the Framingham Study. Calcif Tissue Int 2006; 78:1-8.

XXVIII. Pariente-Rodrigo E, Sgaramella GA, Olmos-Martínez JM et al. Relationship between diffuse idiopathic skeletal hyperostosis, abdominal aortic calcification and associated metabolic disorders: Data from the Camargo Cohort. Med Clin (Barc). 2017 Mar 7. [Epub ahead of print]

XXIX. Tsukahara S, Miyazawa N, Akagawa H et al. COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese. Spine (Phila Pa 1976). 2005 Oct 15; 30(20):2321-4.

XXX. Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthritis Cartilage 2009; 17:825-8.

XXXI. Kiss C, Szilágyi M, Paksy A, et al. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 2002; 41:27-30.

XXXII. Sencan D, Elden H, Nacitarhan V, Sencan M, Kaptanoglu E. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int 2005; 25:518-21.

XXXIII. Mader R, Novofestovski I, Adawi M, et al. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum 2009; 38:361-5.

XXXIV. Mader R, Dubenski N, Lavi I. Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis. Rheumatol Int 2005; 26:132-6.

XXXV. Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Curr Opin Rheumatol 2009; 21:50-4.

XXXVI. Berthelot JM, Le Goff B, Maugars Y. Pathogenesis of hyperostosis: a key role for mesenchymatous cells? Joint Bone Spine. 2013 Dec; 80(6):592-6.

XXXVII. Orden AO, David JM, Díaz RP, Nardi NN, Ejarque AC, Yöchler AB. Association of diffuse idiopathic skeletal hyperostosis and aortic valve sclerosis. Medicina (B Aires). 2014; 74(3):205-9.

XXXVIII. Denko CW, Malemud CJ. Role of the growth hormone/ insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 2005; 35:24-34.

XXXIX. Denko CW, Malemud CJ. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH). Rheumatol Int 2006; 26: 292-7.

XL. Atzeni F, Sarzi-Puttini P, Bevilacqua M. Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). Rheum Dis Clin North Am 2006; 32:413-26.

XLI. Ikeda Y, Nakajima A, Aiba A et al. Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament. Eur Spine J. 2011 Sep; 20(9):1450-8.

XLII. Pappone N, Ambrosino P, Di Minno MN et al. Is diffuse idiopathic skeletal hyperostosis a disease or a syndrome? Need for studies on angiogenesis-stimulating activity. Rheumatology (Oxford). 2016 Dec 24. [Epub ahead of print].

XLIII. Zincarelli C, Iervolino S, Di Minno MN et al. Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1765-9.

XLIV. Pillai S, Littlejohn G. Metabolic factors in diffuse idiopathic skeletal hyperostosis - a review of clinical data. Open Rheumatol J. 2014 Dec 19; 8:116-28.